Enhanced cross-priming of naive CD8+ T cells by dendritic cells treated by the IMiDs® immunomodulatory compounds lenalidomide and pomalidomide. (2013)
Attributed to:
MRC Centre for Transplantation
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/imm.12087
PubMed Identifier: 23374145
Publication URI: http://europepmc.org/abstract/MED/23374145
Type: Journal Article/Review
Volume: 139
Parent Publication: Immunology
Issue: 3
ISSN: 0019-2805